At-Home HPV kits could boost cervical cancer screening in rural areas
NCT ID NCT07294066
First seen Jun 25, 2026 · Last updated Aug 19, 2026 · Updated 3 times
Summary
This study tests whether community health workers can help women in rural North Carolina use at-home HPV self-collection kits to screen for cervical cancer. About 112 women aged 30-64 who haven't been screened recently will receive kits through local organizations. The goal is to see if this approach is feasible and acceptable, and to connect those who test positive with follow-up care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Human papillomavirus (HPV) self-collection kit
- What this could lead to
- If successful, this approach could make cervical cancer screening more accessible for women in rural areas who are overdue for testing.
- What could go wrong
- This is a small pilot study (112 participants) testing feasibility, not effectiveness. It may not lead to widespread use or prove that screening reduces cancer rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 112 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 64 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Woman participants Inclusion Criteria: * Resident of Lenoir County and 12 community. * have not received a Pap test within the last 3.5 years, or an HPV test in the last 5.5 years * female ≥ 30 to 64 years of age at time of recruitment Exclusion Criteria: * 65 years of age or older had a hysterectomy, * history of cervical cancer, * plan to move from Lenoir County during the study period. Community partners participants Inclusion Criteria: * community health workers * clinic staff * community-based organization staff. Exclusion Criteria: • None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pulsed radiation extend life in metastatic cervical cancer?
- Robotic surgery vs standard approaches: does the platform change cancer outcomes?
- New antibody aims to preserve immune checkpoint while fighting cancer
- Smart speculum could bring cervical cancer screening to remote areas
- Your gut bacteria may hold the key to whether immunotherapy works
- Amazon plant put to the test against Cancer's relentless tiredness